Plain-English translation of NCT06343597 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a retrospective study — meaning researchers will look back at medical records of esophageal cancer patients to understand a simple but important question: do hospitals that perform more esophageal cancer surgeries have better results? The study will also examine how different treatment approaches (medicines given before or after surgery) affect survival rates.
Esophageal cancer is often found at an advanced stage and has a serious outlook. Doctors have noticed in other cancers (like pancreatic cancer) that patients treated at high-volume centers — hospitals that do many of these procedures — tend to have better outcomes. This study will help determine if the same is true for esophageal cancer, so patients and their doctors can make the best treatment decisions.
You likely qualify if…
You likely don't qualify if…
This is not an active treatment study — you will not need to take new medications or undergo procedures as part of this research. Instead, researchers will review your existing medical records to gather information about your diagnosis, the hospital where you received treatment, the surgery you had, and any medicines you received before or after surgery. Your participation involves allowing the study team to access and analyze this information.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States
Enrollment target
~30 participants
Started
June 2020
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Crystee Cooper, DHEd
Methodist Health System
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.